It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Comél-Netherton syndrome is a rare autosomal recessive genodermatosis characterized by a triad of manifestations, such as ichthyosis linearis circumflexa, characteristic hair shaft deformities and atopic diathesis. Conservative treatment consists of emollients, keratolytics and antibiotics. Here we present a case of 16-year-old female patient, hospitalized at the Department of Dermatology of Poznan University of Medical Sciences and diagnosed as Netherton syndrome. The patient was treated with medium doses of UVA1 radiation (40-60 J/cm2) generated by GP-24H (Cosmedico, Germany). The expositions were performed tree times weekly, 20 exposures, up to the total dose of 970 J/cm2 have been proposed in the treatment. Clinical improvement of both types of skin lesions i.e. ichthyotic and eczematous was observed. But after cessation of phototherapy they gradually relapsed after approximately 4 months. Later as the patient was treated with small doses of systemic corticosteroids without any clinical effect. Thereafter systemic retinoids were introduced but although they caused satisfactory clinical improvement severe hair loss developed leading to the withdrawn of the medication. The above results underlined that due to the complexity of etiopathogenesis as well as clinical diversity treatment of Netherton Syndrome remains to be a great challenge for the physicians.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer